Get the Stockscreener App
6.29
1.41%
-0.09
After Hours:
6.25
-0.04
-0.64%
Nyxoah Sa stock is traded at $6.29, with a volume of 58,804.
It is down -1.41% in the last 24 hours and up +20.04% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$6.38
Open:
$6.6
24h Volume:
58,804
Relative Volume:
0.61
Market Cap:
$239.54M
Revenue:
$4.71M
Net Income/Loss:
$-46.77M
P/E Ratio:
-3.7458
EPS:
-1.6792
Net Cash Flow:
$-60.34M
1W Performance:
+8.45%
1M Performance:
+20.04%
6M Performance:
+2.28%
1Y Performance:
-34.48%
1-Day Range:
$6.1584
$6.60
1-Week Range:
$5.9714
$6.8745
52-Week Range:
$4.345
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.29 | 239.54M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Will Nyxoah SA stock go up soonMarket Volume Report & Stock Timing and Entry Methods - newser.com
Chart based analysis of Nyxoah SA trendsJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Nyxoah's (NYXH) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
How Nyxoah SA (5YI) stock behaves under inflation pressure2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Intraday pattern recognizer results for Nyxoah SAMarket Trend Review & Safe Capital Preservation Plans - newser.com
What is the fair value estimate for Nyxoah SA (5YI) stock in 2025Portfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Nyxoah SA Stock Analysis and ForecastShort Selling Opportunities & Market Trend Real-Time Reports - earlytimes.in
Applying big data sentiment scoring on Nyxoah SA2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Exit strategy if you’re trapped in Nyxoah SA2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
How to manage a losing position in Nyxoah SAWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Is Nyxoah SA (5YI) stock suitable for passive index funds2025 Key Highlights & Weekly Setup with ROI Potential - newser.com
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System - Yahoo Finance
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System - Sahm
Nyxoah stock surges after first commercial US implants - Investing.com
US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder - Stocktwits
First U.S. Genio® commercial implants — Nyxoah gains CMS coverage, surgeon training and VAC approvals - Stock Titan
Nyxoah Expands in the Middle East to Provide Wider Access to Genio - MSN
Publication relating to transparency notifications - GlobeNewswire
What analysts say about Nyxoah SA stockVolume Weighted Average Price & Beat the Market with AI Reports - earlytimes.in
Nyxoah SA 5YI Stock Analysis and ForecastStock Valuation Metrics & Low Cost Wealth Investment - earlytimes.in
Is Nyxoah SA a good long term investmentRetail Trading Trends & What the Pros Are Saying About This Stock - earlytimes.in
What analysts say about Beijer Alma AB publ 6O4 stockBreakout Stock Watch & Register for the Next Free Workshop - earlytimes.in
Does Nyxoah's Patent Lawsuit Alter the Bull Case for Inspire Medical Systems (INSP)? - simplywall.st
Nyxoah Expands Middle East Presence with New Centers - TipRanks
Nyxoah expands neuromod for sleep apnea to Middle East - MassDevice
Nyxoah Enters Underwriting Agreement for Public Offering - TipRanks
Nyxoah Provides an Update on Expanded Middle East Presence - GlobeNewswire
Revolutionary Sleep Apnea Treatment: Nyxoah's Genio System Expands Across Middle East Healthcare Hubs - Stock Titan
Nyxoah Leads The Charge In European Penny Stocks - simplywall.st
Rally Mode: Is now the right time to enter Nyxoah SAQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - خودرو بانک
Bank Watch: Does Nyxoah SA have a competitive edgeJuly 2025 Recap & Detailed Earnings Play Strategies - خودرو بانک
Geopolitics Watch: Will Nyxoah SA outperform during market ralliesWeekly Stock Report & Technical Buy Zone Confirmations - خودرو بانک
Will Nyxoah SA continue its uptrendJuly 2025 Patterns & Fast Entry High Yield Tips - newser.com
Understanding Nyxoah SA’s price movement2025 Volatility Report & AI Powered Buy/Sell Recommendations - newser.com
Trend analysis for Nyxoah SA this weekWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
Winners Losers: Is Nyxoah SA stock undervalued right nowBreakout Watch & Verified Momentum Watchlists - khodrobank.com
Aug Swings: Will Nyxoah SA outperform during market rallies2025 Performance Recap & Expert Curated Trade Setup Alerts - khodrobank.com
Custom watchlist performance reports with Nyxoah SASwing Trade & Daily Stock Trend Reports - newser.com
Is Nyxoah SA still worth holding after the dipJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.84%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):